Use of Primate Pediatric Model

Pediatric Nonclinical Drug Testing: Principles, Requirements, and Practices

Volumn , Issue , 2012, Pages 255-279

  Weinbauer, Gerhard F ^a   Chellman, Gary J ^b   Rasmussen, Allan Dahl ^c   Vogelwedde, Elvira ^a  

^a Developmental and Reproductive Toxicology   (Germany)

^b CHARLES RIVER LABORATORIES   (United States)

^c H LUNDBECK A S   (Denmark)

Author keywords

Juvenile nonhuman primate model, cynomolgus monkey (Macaca fascicularis); Juvenile toxicity studies in cynomolgus monkeys, pros and cons; Postnatal development of organ systems, functions in cynomolgus monkeys

Indexed keywords

EID: 84886209943     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118168226.ch13     Document Type: Chapter

References (57)

1. Committee for Human Medicinal Products (CHMP). Guideline on the need for nonclinical testing in juvenile animals on human pharmaceuticals for pediatric indications. Doc. Ref. EMEA/CHMP/SWP/169215/2005. 2008 Jan 24.
2. Guidance for Industry: Nonclinical Safety Evaluation of Pediatric Drug Products, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). 2006 Feb.
3. Hurtt ME. Juvenile toxicity testing and a role for the nonhuman primate. In: Weinbauer GF, Vogel F, editors. Critical contributions of primate models for biopharmaceutical drug development. M̈unster: Waxmann Verlag; 2008. pp. 83-100.
4. Mann DR, Akinbami MA, Lunn SF, Fraser HM, Gould KG, Ansari AA. Endocrineimmune interaction: alterations in immune function resulting from neonatal treatment with a GnRH antagonist and seasonality in male primates. Am J Reprod Immunol 2000;44:30-40.
5. Steiner RA, Bremner WJ. Endocrine correlates of sexual development in the male monkey, Macaca fascicularis. Endocrinology 1981;109:914-919.
6. Bercu BB, Lee BC, Pineda JL, Spiliotis BE, Denman DW, Hoffman HJ, Brown TJ, Sachs HC. Male sexual development in the monkey. I. Cross-sectional analysis of pulsatile hypothalamic-pituitary-testicular function. J Clin Endocrinol Metab 1983; 56:1214-1226.
7. Meussy-Dessolle N, Dang DC. Plasma concentrations of testosterone, dihydrotestosterone, delta4-androstenedione, dehydroepiandrosterone and oestradiol-17beta in the crab-eating monkey (Macaca fascicularis) from birth to adulthood. J Reprod Fertil 1985;74:347-349.
8. Andrade MC, Ribeiro CT, Silva VF, Molinaro EM, Goncalves MA, Marques MA, Cabello PH, Leite JP. Biologic data of Macaca mulatta, Macaca fascicularis, and Saimiri sciureus used for research at the Fiocruz primate center. Mem Inst Oswaldo Cruz 2004;99(6):581-589.
9. Golub MS, Gershwin GE. Standardized neonatal assessment in the rhesus monkey. In: Nathanielz PW, Parer JT, editors. Research in perinatal medicine. Perinatology Press; 1984. pp. 55-86.
10. Beck MJ, Padgett EL, Bowman CJ, Wilson DT, Kaufman LE, Varsho BJ, Stump DS, Nemec MD, Holson JF. Nonclinical juvenile toxicity testing. In: Hood RD, editor. Developmental and reproductive toxicology. Boca Raton (FL): CRC Press; 2006. pp. 263-327.
11. Paule MG. Automated assessment of cognitive function in macaques. In: Weinbauer GF, Vogel F, editors. Critical contributions of primate models for biopharmaceutical drug development. M̈unster: Waxmann Verlag; 2008. pp. 113-124.
12. Baldrick P. Developing drugs for pediatric use: a role for juvenile studies? Reg Toxicol Pharmacol 2004;39:381-389.
13. Plant TM. The male monkey as a model for the study of the neurobiology of puberty onset in man. Mol Cell Endocrinol 2006;254/255:97-102.
14. Terasawa E, Fernandez DL. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 2001;22:111-151.
15. Mann DR. Neonatal endocrine activation and development of the primate reproductive and immune system. In: Weinbauer GF, Buse E, M̈uller W, Vogel F, editors. New developments and challenges in primate toxicology. M̈unster: Waxmann Verlag; 2005. pp. 33-62.
16. Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP. What's so special about the developing immune system? Int J Toxicol 2008;27: 223-254.
17. Buse E. Development of the immune system in the cynomolgus monkey: the appropriate model in human targeted toxicology. J Immunotoxicol 2005;2:211-216.
18. Buse E, Habermann G, Vogel F. Thymus development in Macaca fascicularis (Cynomolgus monkey): an approach for toxicology and embryology. J Mol Histol 2006;37(3-4): 161-170.
19. Buse E, Habermann G, Osterburg I, Korte R, Weinbauer GF. Reproductive/ developmental toxicity and immunotoxicity assessment in the nonhuman primate model. Toxicology 2003;185:221-227.
20. Hendrickx AG, Makori N, Peterson P. The nonhuman primate as a model of developmental immunotoxicity. Hum Exp Toxicol 2002;21:537-542.
21. Weinbauer GF, Frings W, Fuchs A, Niehaus M, Osterburg I. Reproductive/ developmental toxicity assessment of biopharmaceuticals in nonhuman primates. In:Cavagnaro JA, editor. Preclinical safety evaluation of biopharmaceuticals. New Jersey: John Wiley and Sons; 2008. pp. 379-398.
22. Golub MS, Gershwin ME, Hurley LS, Hendrickx AG, Saito WY. Studies of marginal zinc deprivation in rhesus monkeys: infant behaviour. Am J Clin Nutr 1985;42: 1229-1239.
23. Golub MS, Sassenrath EN, Chapman LF. Mother-infant interaction in rhesus monkeys treated clinically with delta-9-terahydrocannabiol. Child Dev 1981;52:389-392.
24. Rasmussen AD, Nelson J, Chellman G, Golub M, McAnulty PA. Use of barusiban in a novel study design for evaluation of tocolytic agents in pregnant and neonatal monkeys, including behavioural and immunological endpoints. Reprod Toxicol 2007;23:471-479.
25. Wood LS, Beyer KB, Cappon GD. Species comparison of postnatal CNS development: functional measures. In: Hood RD, editor. Developmental and reproductive toxicology. Boca Raton (FL): CRC Press; 2006. pp. 1103-1130. (Appendix C-8).
26. Weinbauer G, Habermann G, Osterburg I, Kaspareit J, Friderichs-Gromoll S, Srivastav S, Mueller W, Vogel F. Immunological, hematological and clinical pathology parameters during postnatal development in the cynomolgus monkey: preliminary findings. Toxicologist 2004;78(S1):431.
27. Zoetis T, Hurtt ME. Species comparison of lung development. In: Hood RD, editor. Developmental and reproductive toxicology. Boca Raton (FL): CRC Press; 2006. pp. 1022-1028. (Appendix C-3).
28. Hislop A, Howard S, Fairweather DVI. Morphometric studies on the structural development of the lung in Macaca fascicularis during fetal and postnatal life. J Anat 1984;138:95-112.
29. Zuehlke U, Srivastav S, Stanley MA, Vogel F, Korte R, Mueller W, Weinbauer GF. Cynomolgus monkeys of Mauritian origin: reference data and comparison to Chinese/Vietnamese animals. In: Weinbauer GF, Vogel F, editors. Novel approaches towards primate toxicology. M̈unster: Waxmann Verlag; 2006. pp. 185-202.
30. Auyeung-Kim D, Lappin P, Migone T-S, Cai W, Halpern W, Chellman G. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab. Toxicologist 2007;96(1):92.
31. Denny T, Yogev R, Gelman R, Skuza C, Oleske J, Chadwick E, Cheng SC, Connor E. Lymphocyte subsets in healthy children during the first 5 years of life. J Am Med Assoc 1992;267(11):1484-1488.
32. Heldrup J, Kalm O, Prellner K. Blood T and B lymphocyte subpopulations in healthy infants and children. Acta Paediatr 1992;81(2):125-132.
33. Baroncelli S, Panzini G, Geraci A, Pardini S, Corrias F, Iale E, Varano F, Turillazzi PG, Titti F, Verani P. Longitudinal characterization of CD4, CD8T-cell subsets and of haematological parameters in healthy newborns of cynomolgus monkeys. Vet Immunol Immunopathol 1997;59(1-2):141-150.
34. DeMaria MA, Casto M, O'Connell M, Johnson RP, Rosenzweig M. Characterization of lymphocyte subsets in rhesus macaques during the first year of life. Eur J Haematol 2000;65(4):245-257.
35. Hodge S, Hodge G, Flower R, Han P. Cord blood leukocyte expression of functionally significant molecules involved in the regulation of cellular immunity. Scand J Immunol 2001;53(1):72-78.
36. Frings W, Weinbauer G. Flow cytometry-based evaluation of lymphocyte subsets and natural killer cell activity in developing and adult cynomolgus monkeys. Toxicologist 2004;78(S1):430.
37. Voormolen-Kalova M, Van den Berg P, Radl J. Immunoglobulin levels as related to age in nonhuman primates in captivity. II. Rhesus monkeys. J Med Primatol 1974;3: 343-350.
38. Hendrickx AG, Peterson PE, Makori NM. The nonhuman primate as a model of developmental immunotoxicity. In: Halladay SD, editor. Developmental immunotoxicology. Boca Raton (FL): CRC Press; 2005. pp. 117-136.
39. Terao K. Serum immunoglobulin levels in relation to age in the cynomolgus monkey. Jpn J Med Sci Biol 1981;34:246-249.
40. Fujimoto K, Terao K, Cho F, Honjo S. The placental transfer of IgG in the cynomolgus monkey. Jpn J Med Sci Biol 1983;36:171-176.
41. Fujimoto K, Terao K, Cho F, Nakamura F, Honjo S. Age-related immunoglobulin levels in cynomolgus monkeys. Jpn J Med Sci Biol 1982;35:17-23.
42. Coe CL, Kemnitz JW, Schneider ML. Vulnerability of placental antibody transfer and fetal complement synthesis to disturbance of the pregnant monkey. J Med Primatol 1993;22(5):294-300.
43. Brazelton TB. Neonatal behavioral assessment scale, clinics in developmental medicine, No. 50. London: Spastics International Medical Publications; 1973. Brazelton TB, Nugent JK. The neonatal behavioral assessment scale. Cambridge: Mac Keith Press; 1995.
44. Golub MS. Use of monkey neonatal neurobehavioral test batteries in safety testing protocols. Neurotoxicol Teratol 1990;12:537-541.
45. Champagne F, Diorio J, Sharma S, Meaney MJ. Naturally occurring variations in maternal behaviour in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc Natl Acad Sci U S A 2001;98:12736-12741.
46. Pedersen CA, Boccia ML. Oxytocin links mothering received, mothering bestowed and adult stress responses. Stress 2002;5:259-267.
47. Winslow JT, Noble PL, Lyons CK, Sterk SM, Insel TR. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology 2003;28:910-918.
48. Winslow JT, Insel TR. The social deficits of the oxytocin knockout mouse. Neuropeptides 2002;36:221-229.
49. Robinson K, Varela A, Doyle N, Jolette J, Luc C, Sabourin M, Chevrier C, Smith SY. Feasibility study to assess skeletal development in non-clinical pediatric studies. Toxicologist 2004;78(S1):432-433.
50. Smith SY. Charles River Preclinical Services; Montreal, Canada. Personal communication. 2008 Dec 4.
51. Partsch CJ, Korte R, Scḧonau E, Schiedermaier U, Weinbauer GF. Developmental changes of bone age and bone density in the purpose-bred male cynomolgus monkey (Macaca fascicularis): effects of castration. In: Korte R, Weinbauer GF, editors. Towards new horizons in primate toxicology. M̈unster: Waxmann Verlag; 2000. pp. 83-110.
52. Partsch CJ, Bee W, Korte R, Sippell WG, Nieschlag E, Weinbauer GF. Assessment and regulation of bone age and bone density in cynomolgus monkeys (Macaca fascicularis). In: Weinbauer GF, Korte R, editors. Reproduction in nonhuman primates. M̈unster: Waxmann Verlag; 1999. pp. 163-198.
53. Tanner JM, Whitehouse RH, Marshall WA, Healy MJR, Goldstein H. Assessment of skeletal maturity and prediction of adult height (TW2-method). London: Academic Press; 1983.
54. Zoetis T, Tassinari MS, Bagi C, Walthall K, Hurtt ME. Species comparison of postnatal bone growth and development. In: Hood RD, editor. Developmental and reproductive toxicology. Boca Raton (FL): CRC Press; 2006. pp. 969-1004. (Appendix C-1).
55. Gendron RM, Dumont S, Smith SY, Lemire I. Juvenile monkey toxicology studies: testing considerations. Int J Toxicol 2009;28(1):45-46.
56. Lebrec H, Cowan L, Lagrou M, Krejsa C, Neradilek MB, Polissar NL, Black L, Bussiere J. An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: T-cell-dependent antibody responses. J Immunotoxicol 2011;2011:1-13.
57. Morford LL, Bowman CJ, Blanset DL, Bogh IB, Chellman GJ, Halpern WJ, Weinbauer GF, Coogan TP. Preclinical safety evaluations supporting pediatric drug development with biopharmaceutcials: strategy, challenges, current practices. Birth Def Res B 2011;92:359-380.